RECURRENT CERVICAL CARCINOMA
Clinical trials for RECURRENT CERVICAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT CERVICAL CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT CERVICAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise against tough cervical cancer
Disease control OngoingThis study tests whether combining two drugs, dostarlimab and cobolimab, can shrink tumors or slow the disease in people with advanced or recurrent cervical cancer. About 66 participants with measurable tumors will receive the combination. The main goal is to see how many patient…
Matched conditions: RECURRENT CERVICAL CARCINOMA
Phase: PHASE2 • Sponsor: Meghan Shea • Aim: Disease control
Last updated May 16, 2026 23:58 UTC
-
Immunotherapy drug shows promise for Tough-to-Treat cervical cancer
Disease control OngoingThis study tested a drug called nivolumab in 26 women with cervical cancer that had come back or spread despite other treatments. Nivolumab helps the immune system attack cancer cells. The goal was to see if the drug could shrink tumors and how safe it was. While not a cure, it o…
Matched conditions: RECURRENT CERVICAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Blood test may tame Chemo's nerve damage
Knowledge-focused TerminatedThis study looks at whether doctors can consistently measure the chemotherapy drug paclitaxel in the blood of cancer patients. The goal is to see if this could help adjust doses to kill cancer while reducing nerve damage, a common side effect. About 22 adults with various solid t…
Matched conditions: RECURRENT CERVICAL CARCINOMA
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated May 17, 2026 00:01 UTC
-
Gene test trial aims to outsmart advanced cancers
Knowledge-focused OngoingThis study tests whether analyzing the genes of a patient's tumor can help doctors choose a more effective treatment. Over 6,400 adults with advanced solid tumors, lymphomas, or multiple myeloma that have not responded to standard therapy are enrolled. The goal is to see if targe…
Matched conditions: RECURRENT CERVICAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 16, 2026 23:56 UTC
-
Blood test may predict cervical cancer treatment success
Knowledge-focused OngoingThis study collects blood samples from 18 people with cervical cancer to see if HPV DNA from the tumor can be detected in the blood. Researchers hope this information can help predict how well treatment works and catch cancer early if it comes back. The study is observational and…
Matched conditions: RECURRENT CERVICAL CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC